Spectrum Management Group’s GSK GSK Stock Holding History

Spectrum Management Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-9,960	Closed	-$505K	–	319
2017 Q3	$505K	Buy	+9,960	New	+$505K	0.16%	84

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Spectrum Management Group's GSK Position: Q4 2017 in Review

Spectrum Management Group sold out of GSK (GSK) in Q4 2017, closing a stake of 9,960 shares — an estimated $505K sold.

Spectrum Management Group first reported a position in GSK in Q3 2017 and held it in 1 quarter. The position peaked at $505K in Q3 2017. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

Spectrum Management Group reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
Spectrum Management Group sold 9,960 GSK shares in Q4 2017, an estimated $505K.
Spectrum Management Group first reported a position in GSK in Q3 2017 and held it in 1 quarter.
Spectrum Management Group's GSK position peaked at $505K in Q3 2017.
763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Spectrum Management Group's 13F filing for Q4 2017, filed 7 Feb 2018.